Form 4: Director Erica J. Rogers Acquires Ceribell Shares

Director Erica J. Rogers acquired 7,838 restricted stock units in Ceribell, Inc. as reported in a recent SEC Form 4 filing.

Summary

• Director Erica J. Rogers was granted 7,838 restricted stock units (RSUs) of Ceribell, Inc. (CBLL) common stock.
• The transaction occurred on June 2, 2026.
• Following this transaction, the total number of securities beneficially owned by the director is 33,054 shares.
• The shares were acquired at a price of $0 per share, representing an equity grant.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation.

Positives

• Director alignment with company performance through increased equity ownership.
• Total beneficial ownership increased to 33,054 shares.

Negatives

• None identified.

Risks

• Standard market risks associated with equity ownership in a publicly traded company.

Future Outlook

Not applicable as this is a routine insider transaction filing.

Industry Context

StockSavvy.ai notes that director equity grants are standard corporate governance practices intended to align leadership interests with long-term shareholder value in the medical technology sector.

Comparison to Industry Standards

• The grant of RSUs to directors is a common practice among mid-cap and growth-stage medical technology companies to ensure retention and alignment.

Stakeholder Impact

• Positive signal for shareholders as it demonstrates director commitment to the company.

Next Steps

• Vesting of the granted restricted stock units according to the company's equity incentive plan.

Key Dates

Keywords

Ceribell, CBLL, Form 4, Insider Transaction, Director, Equity Grant